R
RAPT Therapeutics
Biotech & Life Sciences · San Francisco, United States · Founded 2013 · IPO 2019
Develops clinical-stage therapies targeting inflammatory and immunological diseases through small-molecule and biologic drug research MoreLess
RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative oral therapeutics aimed at targeting key drivers of the immune system. The company's mission is to transform the treatment of cancer and inflammatory diseases through cutting-edge science. RAPT Therapeutics primarily serves patients suffering from cancer and inflammatory conditions, offering them new hope through advanced medical treatments. Operating in the biopharmaceutical market, the company leverages its expertise in immunology to create therapies that intelligently target specific pathways within the immune system.
The business model of RAPT Therapeutics revolves around research and development (R&D) of novel drug candidates, which are then advanced through clinical trials. The company generates revenue through partnerships, licensing agreements, and potential future sales of its proprietary drugs once they receive regulatory approval. RAPT Therapeutics also attracts investment opportunities, which help fund its ongoing R&D efforts and clinical trials.
Key clients include healthcare providers, research institutions, and pharmaceutical companies interested in innovative treatments for cancer and inflammatory diseases. The company aims to improve and empower countless lives by offering effective and targeted therapeutic solutions.
Keywords: biopharmaceutical, oral therapeutics, immune system, cancer treatment, inflammation, clinical trials, drug development, immunology, R&D, partnerships.
Talent graph
RAPT Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where RAPT Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$28M patent portfolio · 19 active families
Where RAPT Therapeutics concentrates vs peers
Each axis is a top-10 topic across RAPT Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about RAPT Therapeutics
An AI-synthesized read of the highest-engagement posts about RAPT Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RAPT Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.